BioSig Technologies, Inc. announces a proposed public offering of shares of common stock or pre-funded warrants.
The net proceeds from the offering will be used to purchase gold bullion, for working capital, and general corporate purposes.
The offering is subject to market conditions, and completion details are pending.
Proposed Public Offering
BioSig intends to offer shares of common stock or pre-funded warrants through an underwritten public offering.
Use of Proceeds
Net proceeds to be used for purchasing gold bullion, working capital, and general corporate purposes.
Book-Running Managers
Clear Street and Needham & Company are acting as joint book-running managers of the offering.
- The offering is expected to provide BioSig Technologies with additional funding for its operations and investment policy.
- Participation in the offering may impact the company's financial position and strategic initiatives.
BioSig Technologies' proposed public offering signifies a strategic move to raise capital for gold bullion purchases and corporate needs. The partnership with Clear Street and Needham & Company further strengthens the offering process.